Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives journalArticle 2015 Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J.
Intramuscular administration of alfaxalone for sedation in rabbits journalArticle 2015 Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L.
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study journalArticle 2015 Libé, R.; Borget, I.; Ronchi, C. L.; Zaggia, B.; Kroiss, M.; Kerkhofs, T.; Bertherat, J.; Volante, M.; Quinkler, M.; Chabre, O.; Bala, M.; Tabarin, A.; Beuschlein, F.; Vezzosi, D.; Deutschbein, T.; Borson-Chazot, F.; Hermsen, I.; Stell, A.; Fottner, C.; Leboulleux, S.; Hahner, S.; Mannelli, M.; Berruti, A.; Haak, H.; Terzolo, M.; Fassnacht, M.; Baudin, E.
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies journalArticle 2015 Rini, B.; Goddard, A.; Knezevic, D.; Maddala, T.; Zhou, M.; Aydin, H.; Campbell, S.; Elson, P.; Koscielny, S.; Lopatin, M.; Svedman, C.; Martini, J. F.; Williams, J. A.; Verkarre, V.; Radulescu, C.; Neuzillet, Y.; Hemmerle, I.; Timsit, M. O.; Tsiatis, A. C.; Bonham, M.; Lebret, T.; Mejean, A.; Escudier, B.
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection journalArticle 2015 Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M.
Designs of preoperative biomarkers trials in oncology: a systematic review of the literature journalArticle 2015 Marous, M.; Bieche, I.; Paoletti, X.; Alt, M.; Razak, A. R.; Stathis, A.; Kamal, M.; Le Tourneau, C.
Long-term follow-up of TaG1 non-muscle-invasive bladder cancer journalArticle 2015 Olivier Bosset, P.; Neuzillet, Y.; Paoletti, X.; Molinie, V.; Botto, H.; Lebret, T.
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer journalArticle 2015 Nascimento, C.; Borget, I.; Al Ghuzlan, A.; Deandreis, D.; Hartl, D.; Lumbroso, J.; Berdelou, A.; Lepoutre-Lussey, C.; Mirghani, H.; Baudin, E.; Schlumberger, M.; Leboulleux, S.
Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up journalArticle 2015 Levy, A.; Martelli, H.; Fayech, C.; Minard-Colin, V.; Dumas, I.; Gensse, M. C.; Le Deley, M. C.; Oberlin, O.; Haie-Meder, C.
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials journalArticle 2015 Paoletti, X.; Ezzalfani, M.; Le Tourneau, C.
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead journalArticle 2015 Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C.
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial journalArticle 2015 Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort journalArticle 2015 Dartois, L.; Gauthier, E.; Heitzmann, J.; Baglietto, L.; Michiels, S.; Mesrine, S.; Boutron-Ruault, M. C.; Delaloge, S.; Ragusa, S.; Clavel-Chapelon, F.; Fagherazzi, G.
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study journalArticle 2015 Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E.
Design and statistical principles of the SHIVA trial journalArticle 2015 Paoletti, X.; Asselain, B.; Kamal, M.; Servant, N.; Huppe, P.; Bieche, I.; Le Tourneau, C.
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) journalArticle 2015 Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C.
Cost Of Genome Analysis: The Sanger Sequencing Method journalArticle 2015 Perrier, L.; Heinz, D.; Baffert, S.; Zou, Z.; Durand Zaleski, I.; Rouleau, E.; Wang, Q.; Haddad, V.; Bringuier, P.; Merlio, J.; Caumont, C.; Lacroix, L.; Marino, P.; Borget, I.
Precision medicine for metastatic breast cancer--limitations and solutions journalArticle 2015 Arnedos, M.; Vicier, C.; Loi, S.; Lefebvre, C.; Michiels, S.; Bonnefoi, H.; Andre, F.
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study journalArticle 2015 Jourdain, A.; Auperin, A.; Minard-Colin, V.; Aladjidi, N.; Zsiros, J.; Coze, C.; Gandemer, V.; Bertrand, Y.; Leverger, G.; Bergeron, C.; Michon, J.; Patte, C.
Intramuscular administration of alfaxalone for sedation in rabbits journalArticle 2015 Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L.
Nail toxicities induced by systemic anticancer treatments journalArticle 2015 Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R.
Precision medicine: lessons learned from the SHIVA trial - Authors' reply journalArticle 2015 Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) journalArticle 2015 Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting journalArticle 2015 Antoun, S.; Bayar, A.; Ileana, E.; Laplanche, A.; Fizazi, K.; di Palma, M.; Escudier, B.; Albiges, L.; Massard, C.; Loriot, Y.
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma journalArticle 2015 Squifflet, P.; Michiels, S.; Siegel, D.; Vij, R.; Jagannath, S.; Saad, E. D.; Rajangam, K.; Ro, S. K.; Buyse, M.
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials journalArticle 2015 Dowsett, M.; Forbes, J. F.; Bradley, R.; Ingle, J.; Aihara, T.; Bliss, J.; Boccardo, F.; Coates, A.; Coombes, R. C.; Cuzick, J.; Dubsky, P.; Gnant, M.; Kaufmann, M.; Kilburn, L.; Perrone, F.; Rea, D.; Thürlimann, B.; van de Velde, C.; Pan, H.; Peto, R.; Davies, C.; Gray, R.
Mineralogy and uranium leaching of ores from Triassic Peribaltic sandstones journalArticle 2015 Gajda, D.; Kiegiel, K.; Zakrzewska-Koltuniewicz, G.; Chajduk, E.; Bartosiewicz, I.; Wolkowicz, S.
Primary cutaneous and subcutaneous Ewing sarcoma journalArticle 2015 Di Giannatale, A.; Frezza, A. M.; Le Deley, M. C.; Marec-Bérard, P.; Benson, C.; Blay, J. Y.; Bui, B.; Judson, I.; Oberlin, O.; Whelan, J.; Gaspar, N.
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES journalArticle 2015 Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H.
Nail toxicities induced by systemic anticancer treatments journalArticle 2015 Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R.
[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB] journalArticle 2015 Ezzalfani, M.; Dugue, A.; Mollevi, C.; Pulido, M.; Bonnetain, F.; Filleron, T.; Gal, J.; Gauthier, M.; Le Deley, M. C.; Le Tourneau, C.; Medioni, J.; Nguyen, J. M.; Chabaud, S.; Teixeira, L.; Thivat, E.; You, B.; Kramar, A.; Paoletti, X.
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study journalArticle 2015 Libé, R.; Borget, I.; Ronchi, C. L.; Zaggia, B.; Kroiss, M.; Kerkhofs, T.; Bertherat, J.; Volante, M.; Quinkler, M.; Chabre, O.; Bala, M.; Tabarin, A.; Beuschlein, F.; Vezzosi, D.; Deutschbein, T.; Borson-Chazot, F.; Hermsen, I.; Stell, A.; Fottner, C.; Leboulleux, S.; Hahner, S.; Mannelli, M.; Berruti, A.; Haak, H.; Terzolo, M.; Fassnacht, M.; Baudin, E.
Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians journalArticle 2015 Billaux, M.; Borget, I.; Prognon, P.; Pineau, J.; Martelli, N.
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study journalArticle 2015 Vale, C. L.; Rydzewska, L. H.; Rovers, M. M.; Emberson, J. R.; Gueyffier, F.; Stewart, L. A.; Cochrane, I. P. D. Meta-analysis Methods Group
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models journalArticle 2015 Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia journalArticle 2015 Selimoglu-Buet, D.; Wagner-Ballon, O.; Saada, V.; Bardet, V.; Itzykson, R.; Bencheikh, L.; Morabito, M.; Met, E.; Debord, C.; Benayoun, E.; Nloga, A. M.; Fenaux, P.; Braun, T.; Willekens, C.; Quesnel, B.; Ades, L.; Fontenay, M.; Rameau, P.; Droin, N.; Koscielny, S.; Solary, E.; Francophone Myelodysplasia, Group
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite journalArticle 2015 Grünewald, T. G.; Bernard, V.; Gilardi-Hebenstreit, P.; Raynal, V.; Surdez, D.; Aynaud, M. M.; Mirabeau, O.; Cidre-Aranaz, F.; Tirode, F.; Zaidi, S.; Perot, G.; Jonker, A. H.; Lucchesi, C.; Le Deley, M. C.; Oberlin, O.; Marec-Bérard, P.; Véron, A. S.; Reynaud, S.; Lapouble, E.; Boeva, V.; Rio Frio, T.; Alonso, J.; Bhatia, S.; Pierron, G.; Cancel-Tassin, G.; Cussenot, O.; Cox, D. G.; Morton, L. M.; Machiela, M. J.; Chanock, S. J.; Charnay, P.; Delattre, O.
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial journalArticle 2015 Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E.
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al journalArticle 2015 Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M.